Skip to content

Nanobiotix S.A.

NBTX NNBXF

CIK 0001760854

← back to feed
Revenue (TTM)
€32.59M
+553.2% YoY FY Dec 2025
Net Income (TTM)
−€23.96M
+64.8% YoY FY Dec 2025
EPS Diluted (TTM)
−€0.50
+65.3% YoY FY Dec 2025
Gross Margin
—
FY Dec 2025
Operating Margin
-33.2%
FY Dec 2025
Net Margin
-73.5%
FY Dec 2025
Free Cash Flow (TTM)
—
FY Dec 2025
Cash
€52.75M
FY Dec 2025
Total Debt
—
FY Dec 2025
Shares Outstanding
48.41M sh
FY Dec 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings